Previous Page  10 / 25 Next Page
Information
Show Menu
Previous Page 10 / 25 Next Page
Page Background

Page 62

Notes:

conferenceseries

.com

Volume 8, Issue 3(Suppl)

J Allergy Ther, an open access journal

ISSN: 2155-6121

Allergy-Clinical Immunology 2017

September 07-08, 2017

September 07-08, 2017 | Edinburgh, Scotland

ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY

11

th

International Conference on

Immunomodulatory potency of

Sargassum horneri

via increasing regulatory T cells and suppressing

the mast cell activation

Areum Kim

1

, Jinhee Cho

1

, Sumin Shin

1

, Khinm Herath

1

, Won Jung Lee

1

, Ginnae Ahn

2

, You-Jin Jeon

1

and

Youngheun Jee

1

1

Jeju National University, South Korea

2

Chonnam National University, South Korea

S

argassum horneri

, a species of brown macro algae, has been reported to have several health promoting effects such as

anti-viral, anti-coagulant effect, and anabolic activity on bone metabolism or higher plumbum absorption. In the present

study, we investigated the immunomodulatory activity of

S. horneri

using murine splenocytes and bone marrow cultured

mast cells.

S. horneri

was enzymatically hydrolyzed using the celluclast (SHC). Polyphenol-rich fractions from S. horneri

(SHP) were also used for assessing the anti-allergic activity in BMCMC. SHC induced the proliferation of splenocytes without

cytotoxicity. Treatment with SHC led to a significant increase in the population of CD8+ T cells, CD8+CD25+ regulatory T

cells, and granulocytes. SHC also increased the secretion of IFN-γ. Meanwhile, SHP didn’t show any cytotoxicity in BMCMC

but significantly decreased the release of β-hexosaminidase in stimulated BMCMC. SHP also decreased the mRNA expression

of IL-4, IL-6, IL-13, and TSLP in BMCMC. These findings indicate that

S. horneri

might modulate the Th2-type immune

responses in immune-mediated disease. Therefore,

S. horneri

could be an excellent candidate for an anti-allergic agent.

Biography

Areum Kim is a PhD student at Jeju National University, Republic of Korea. He has research interest in Immunology and Radiobiology. He completed his BA in

Nuclear and Energy Engineering at Jeju national University, South Korea from 2009-2013 and; MS in Interdisciplinary Graduate Program in Advanced Convergence

Technology & Science at Jeju National University, Korea from 2013-2016.

orange5687@naver.com

Areum Kim et al., J Allergy Ther 2017, 8:3(Suppl)

DOI: 10.4172/2155-6121-C1-006